Literature DB >> 9184168

Inhibition of P-glycoprotein ATPase activity by beryllium fluoride.

B Sankaran1, S Bhagat, A E Senior.   

Abstract

ATPase activity of P-glycoprotein (multidrug-resistance protein) was found to be potently inhibited by beryllium fluoride (BeFx) in combination with MgATP, MgADP, or corresponding Mg-8-azido-nucleotides. Inhibition was due to trapping of nucleoside diphosphate at catalytic sites. Full inhibition was achieved on trapping of 1 mol of nucleotide per mol of Pgp. Reactivation was slow (t(1/2) = 32 min at 37 degrees C), and release of trapped nucleotide correlated with recovery of ATPase. Trapping of 8-azido-ADP followed by UV irradiation yielded permanent inactivation and specific labeling of Pgp in plasma membranes. Both N- and C-terminal nucleotide binding sites were labeled. These findings give strong confirmation of the concepts that in intact Pgp both nucleotide sites are active in MgATP hydrolysis, and that they interact strongly. The characteristics of inhibition by BeFx were similar in general to those seen with vanadate. However, PPi gave strong protection against BeFx inhibition, and in this respect, inhibition by BeFx was clearly different from vanadate inhibition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184168     DOI: 10.1021/bi970034s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution.

Authors:  Jin Wang; Fang Sun; Da-wei Zhang; Yongming Ma; Fang Xu; Jitendra D Belani; Jonathan C Cohen; Helen H Hobbs; Xiao-Song Xie
Journal:  J Biol Chem       Date:  2006-07-25       Impact factor: 5.157

Review 2.  The mechanism of action of multidrug-resistance-linked P-glycoprotein.

Authors:  Z E Sauna; M M Smith; M Müller; K M Kerr; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

3.  Molecular-dynamics simulations of the ATP/apo state of a multidrug ATP-binding cassette transporter provide a structural and mechanistic basis for the asymmetric occluded state.

Authors:  Peter M Jones; Anthony M George
Journal:  Biophys J       Date:  2011-06-22       Impact factor: 4.033

4.  Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.

Authors:  Paula L Russell; Frances J Sharom
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

5.  Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein.

Authors:  Z E Sauna; S V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

6.  Dynamic ligand-induced conformational rearrangements in P-glycoprotein as probed by fluorescence resonance energy transfer spectroscopy.

Authors:  Brandy Verhalen; Stefan Ernst; Michael Börsch; Stephan Wilkens
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

7.  A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.

Authors:  Marianne Kluth; Jan Stindt; Carola Dröge; Doris Linnemann; Ralf Kubitz; Lutz Schmitt
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

Review 8.  The occluded nucleotide conformation of p-glycoprotein.

Authors:  Gregory Tombline; Alan E Senior
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 2.945

9.  Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis.

Authors:  G Szakács; C Ozvegy; E Bakos ; B Sarkadi; A Váradi
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

10.  Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.

Authors:  András Kern; Zsófia Szentpétery; Károly Liliom; Eva Bakos; Balázs Sarkadi; András Váradi
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.